MEDICINOVA INC

MNOVSEC EDGAR

Pharmaceutical Preparations(DE)CIK: 1226616

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue from Contract with Customer, Excluding Assessed Tax	$409.7K	$1.0M	$1.0M	$4.0M	$4.0M
Cost of Revenue	—	—	—	—	—
Research and Development Expense	$6.8M	$5.3M	$8.7M	$8.1M	$7.1M
Operating Expenses	$12.7M	$10.9M	$14.6M	$14.3M	$14.2M
Operating Income (Loss)	-$12.7M	-$9.9M	-$14.6M	-$10.2M	-$14.2M
Interest Expense	—	—	—	—	—
Other Nonoperating Income (Expense)	-$39.5K	-$502.9K	-$247.3K	-$59.5K

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$55.9M	$66.3M	$74.2M	$87.4M	$75.4M
Assets, Current	$41.1M	$51.2M	$59.0M	$72.0M	$60.7M
Cash and Cash Equivalents, at Carrying Value	$40.4M	$51.0M	$18.5M	$71.4M	$60.0M
Liabilities	$3.4M	$3.9M	$3.9M	$3.7M	$4.1M
Liabilities, Current	$3.0M	$3.3M	$3.2M	$2.8M	$2.2M
Long-term Debt, Excluding Current Maturities	—	—	—	—	—
Accounts Payable, Current	$1.1M	$1.0M	$424.6K	$402.7K	$616.6K

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	-$10.6M	-$7.4M	-$12.9M	-$9.4M	-$10.8M
Net Cash Provided by (Used in) Investing Activities	-$697.00	$39.9M	-$40.0M	-$28.7K	-$36.5K
Net Cash Provided by (Used in) Financing Activities	$0.00	—	$7.9K	$20.8M	$7.1M
Payments to Acquire Property, Plant, and Equipment	$895.00	$21.3K	$5.0K	$28.7K	$36.5K
Payments for Repurchase of Common Stock	—	—	—	—	—

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)